Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells

Journal of Pathology

Volumn 218, Issue 3, 2009, Pages 391-398

  Shrivastav, Anuraag ^a,b   Varma, Shailly ^a   Senger, Arnie ^b   Khandelwal, Ramji L ^a   Carlsen, Svein ^b   Sharma, Rajendra K ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SASKATCHEWAN CANCER AGENCY   (Canada)

Author keywords

Breast cancer; Diagnosis; Immunohistochemistry; N myristoyltransferase; Phosphorylation; PKB Akt; Tissue array

Indexed keywords

PROTEIN KINASE B; PROTEIN N MYRISTOYLTRANSFERASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GRADING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACYLTRANSFERASES; ADULT; AMINOPEPTIDASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 67650033087     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2550     Document Type: Article

References (34)

1. Mishkind M. Morbid myristoylation. Trends Cell Biol 2001;11:191.
2. Shrivastav A, Selvakumar P, Bajaj G, Lu Y, Dimmock JR, Sharma RK. Regulation of N-myristoyltransferase by novel inhibitor proteins. Cell Biochem Biophys 2005;43:189-202.
3. Selvakumar P, Lakshmikuttyamma A, Shrivastav A, Das SB, Dimmock JR, Sharma RK. Potential role of N-myristoyltransferase in cancer. Prog Lipid Res 2007;46:1-36.
4. Giang DK, Cravatt BF. A second mammalian N-myristoyltransferase. J Biol Chem 1998;273:6595-6598.
5. Gupta D, Khandelwal RL. Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor-alpha in HepG2 cells. Biochim Biophys Acta 2004;1671:51-58.
6. Syed NA, Khandelwal RL. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells. Mol Cell Biochem 2000;211:123-136.
7. Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 1996;271:21920-21926.
8. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003;4:257-262.
9. Schmitz KJ, Otterbach F, Callies R, Levkau B, Holscher M, Hoffmann O, et al. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod Pathol 2004;17:15-21.
10. Park SS, Kim SW. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Oncol Rep 2007;18:139-143.
11. Imanishi Y, Hu B, Jarzynka MJ, Guo P, Elishaev E, Bar-Joseph I, et al. Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res 2007;67:4254-4263.
12. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241.
13. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689.
14. Kennedy SG, Kandel ES, Cross TK, Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 1999;19:5800-5810.
15. Boutin JA. Myristoylation. Cell Signal 1997;9:15-35.
16. Vilas GL, Corvi MM, Plummer GJ, Seime AM, Lambkin GR, Berthiaume LG. Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events. Proc Natl Acad Sci U S A 2006;103:6542-6547.
17. Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000;290:1761-1765.
18. Gupta D, Syed NA, Roesler WJ, Khandelwal RL. Effect of overexpression and nuclear translocation of constitutively active PKB-alpha on cellular survival and proliferation in HepG2 cells. J Cell Biochem 2004;93:513-525.
19. King MJ, Sharma RK. N-myristoyl transferase assay using phosphocellulose paper binding. Anal Biochem 1991;199:149-153.
20. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
21. Shrivastav A, Varma S, Saxena A, DeCoteau J, Sharma RK. N-myristoyltransferase: a potential novel diagnostic marker for colon cancer. J Transl Med 2007;5:58.
22. Varma S, Khandelwal RL. Overexpression of Akt1 upregulates glycogen synthase activity and phosphorylation of mTOR in IRS-1 knockdown HepG2 cells. J Cell Biochem 2007;103:1424-1427.
23. Selvakumar P, Lakshmikuttyamma A, Dimmock JR, Sharma RK. Methionine aminopeptidase 2 and cancer. Biochim Biophys Acta 2006;1765:148- 154.
24. Qiao M, Iglehart JD, Pardee AB. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res 2007;67:5293-5299.
25. Rajala RV, Radhi JM, Kakkar R, Datla RS, Sharma RK. Increased expression of N-myristoyltransferase in gall bladder carcinomas. Cancer 2000;88:1992-1999.
26. Shrivastav A, Singh NK, Tripathi P, George T, Dimmock JR, Sharma RK. Copper(II) and manganese(III) complexes of N′-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer. Biochimie 2006;88:1209-1216.
27. Magnuson BA, Raju RV, Moyana TN, Sharma RK. Increased N-myristoyltransferase activity observed in rat and human colonic tumors. J Natl Cancer Inst 1995;87:1630-1635.
28. Majewski N, Nogueira V, Robey RB, Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 2004;24:730-740.
29. Martin DD, Vilas GL, Prescher JA, Rajaiah G, Falck JR, Bertozzi CR, et al. Rapid detection, discovery, and identification of post-translationally myristoylated proteins during apoptosis using a bioorthogonal azidomyristate analog. FASEB J 2008;22:797-806.
30. Yeatman TJ. A renaissance for SRC. Nature Rev Cancer 2004;4:470-480.
31. Dehm SM, Bonham K. SRC gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol 2004;82:263-274.
32. Bhandarkar SS, Bromberg J, Carrillo C, Selvakumar P, Sharma RK, Perry BN, et al. Tris (dibenzylideneacetone) dipalladium, a N- myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo. Clin Cancer Res 2008;14:5743-5748.
33. Pincheira R, Castro AF, Ozes ON, Idumalla PS, Donner DB. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol 2008;181:1288-1298.
34. Chang YM, Bai L, Liu S, Yang JC, Kung HJ, Evans CP. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 2008;27:6365-6375.